Upgrade to SI Premium - Free Trial

Amicus Therapeutics (FOLD) PT Lowered to $14 at BofA Securities

February 19, 2025 1:48 PM
BofA Securities analyst Tazeen Ahmad lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $14.00 (from $15.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles